European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.

Mission

The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'

European Drug Report 2020

Published by
EMCDDA
Publication Date

European Drug Report 2020

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets 
What do the latest data tell us about drug production and trafficking trends?

European Drug Report 2020 Launch

Lisbon,

How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends? Be the first to know when the EU drugs agency (EMCDDA) launches its European Drug Report 2020: Trends and Developments in a live online media event on 22 September.

EMCDDA webinar: COVID-19 and drug policy

Lisbon,

Background: this is the 6th EMCDDA webinar on the Coronavirus. It will be exploring with the help of three experts from Northern, Central, Southern European EU countries (Finland, Greece and The Netherlands) whether the COVID-19 related emergency is having or is going to have any impact on Drugs Policy.

How is COVID-19 shaping the future of drug services in Europe?

Webinar,

The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for discussion on emerging challenges.

Coronavirus and drug-related issues: are we ready to learn the lessons?

Webinar,

The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for discussion on emerging challenges. 

EU4MD Bursaries for the 2020 NIDA International Forum

Professionals, academics and experts from European Neighbourhood Policy (ENP) countries will have the opportunity to participate in the 2020 National Institute on Drug Abuse International Forum, thanks to five bursaries being offered through the EU4Monitoring Drugs (EU4MD) project. The three-year EU-funded project — launched by the EMCDDA in January 2019 — supports national and regional readiness in the ENP area to identify and respond to drug-related health and security threats. The forum — organised by